Researchers recently tested a medicine called AD109 in a large phase 3 clinical trial and found encouraging results. The treatment is a once-nightly oral pill designed specifically for obstructive ...

Saliva is important for our health, but even a little dribble can be embarrassing. Experts explain why it happens.

Sound Sleep Medical assists patients to determine whether sleep apnea might be behind their constant fatigue, loud snoring, and daytime drowsiness. Free ...

AD109, an investigational once-daily oral combination of aroxybutynin and atomoxetine, significantly improved airway ...

Vaping is often marketed as a safer alternative to smoking, but experts warn it may harm the lungs, heart and oral health.

A once-nightly oral pill helped control obstructive sleep apnea in a large, phase 3 clinical trial presented at the 2026 ATS International Conference.

Upper Michigan Today welcomes American Academy of Dental Sleep Medicine President Dr. Paul Jacobs to share more of his ...

Alesis LLC, the U.S. distributor of the Alesis OSA1™ medical device, today announced a joint venture partnership with Dr. Lyly Fisher, DDS, Diplomate, ABDSM, ASBA -- a dual board-certified sleep ...

A once-nightly oral pill helped control obstructive sleep apnea in a large, Phase III clinical trial presented at the 2026 ...

AD109 works by targeting neuromuscular dysfunction of upper airway muscles during sleep, representing a potential new ...

Could strengthening your tongue and throat muscles help your OSA? Explore the science behind myofunctional therapy, how it works, and if it’s a viable alternative to CPAP.